Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors.
Clin Cancer Res
; 15(9): 3177-83, 2009 May 01.
Article
in En
| MEDLINE
| ID: mdl-19383817
Full text:
1
Database:
MEDLINE
Main subject:
Oligodeoxyribonucleotides
/
Thionucleotides
/
DNA (Cytosine-5-)-Methyltransferases
/
Enzyme Inhibitors
/
Neoplasms
/
Antineoplastic Agents
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2009
Type:
Article
Affiliation country:
United kingdom